Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.57 |
| ▸ | POLB | P06746 | 2/20 | 0.56 |
| ▸ | GAA | P10253 | 1/20 | 0.56 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.47 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | HTR1A | P08908 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.43 |
| ▸ | GLA | P06280 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22840863 | 0.98 | KDM4E (0.55) | KDM4EALDH1A1POLBGAATSHR | |
| SCHEMBL525957 | 0.98 | KDM4E (0.55) | KDM4EALDH1A1POLBGAATSHR | |
| SCHEMBL18024033 | 0.92 | KDM4E (0.53) | KDM4EALDH1A1POLBGAATSHR | |
| SCHEMBL111438 | 0.89 | TSHR (0.58) | KDM4EALDH1A1TSHRSMN1; SMN2KEAP1 | |
| SCHEMBL4376068 | 0.88 | ALDH1A1 (0.53) | KDM4EALDH1A1POLBGAATSHR | |
| SCHEMBL7106263 | 0.87 | TSHR (0.61) | KDM4EALDH1A1POLBTSHRSMN1; SMN2 | |
| SCHEMBL20118622 | 0.85 | KDM4E (0.54) | KDM4EALDH1A1POLBGAATSHR | |
| SCHEMBL8966405 | 0.84 | — | — | |
| SCHEMBL4905012 | 0.84 | HTR1A (0.54) | KDM4EALDH1A1TSHRSMN1; SMN2HTR1A | |
| SCHEMBL18024017 | 0.84 | KDM4E (0.53) | KDM4EALDH1A1POLBGAATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 313 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250277171-A1 | COMPOSITION FOR POST-CMP CLEANING | ENTEGRIS, INC. | 2025-09-04 | — | — | US | claimed |
| US-20250179233-A1 | PROCESS AND CATALYSTS FOR HYDROGEN MEDIATED ANIONIC COPOLYMERIZATION OF CONJUGATED DIENES AND LIQUID COPOLYMERS THEREOF | ALBEMARLE CORPORATION (US) | 2025-06-05 | — | — | US | claimed |
| CN-119528847-A | DMAEEM method for co-producing DMDEE and application of DMAEEM | 安徽恒光聚氨酯材料有限公司 | 2025-02-28 | — | — | CN | claimed |
| EP-4486808-A2 | PROCESS AND CATALYSTS FOR HYDROGEN MEDIATED ANIONIC COPOLYMERIZATION OF CONJUGATED DIENES AND LIQUID COPOLYMERS THEREOF | ALBEMARLE CORPORATION (US) | 2025-01-08 | — | — | EP | claimed |
| CN-111741949-B | Method for continuously separating a mixture comprising Morpholine (MO), monoaminodiglycol (ADG), ammonia, water and Methoxyethanol (MOE) by distillation | 巴斯夫欧洲公司 | 2024-03-15 | — | — | CN | claimed |
| US-20240034825-A1 | PROCESS AND CATALYSTS FOR HYDROGEN MEDIATED ANIONIC POLYMERIZATION OF CONJUGATED DIENES AND LIQUID POLYMERS THEREOF | ALBEMARLE CORPORATION | 2024-02-01 | — | — | US | claimed |
| WO-2023168218-A2 | PROCESS AND CATALYSTS FOR HYDROGEN MEDIATED ANIONIC COPOLYMERIZATION OF CONJUGATED DIENES AND LIQUID COPOLYMERS THEREOF | ALBEMARLE CORPORATION (US) | 2023-09-07 | — | — | WO | claimed |
| EP-4208485-A1 | PROCESS AND CATALYSTS FOR HYDROGEN MEDIATED ANIONIC POLYMERIZATION OF CONJUGATED DIENES AND LIQUID POLYMERS THEREOF | ALBEMARLE CORPORATION (US) | 2023-07-12 | — | — | EP | claimed |
| CN-116368159-A | Process and catalyst for hydrogen-mediated anionic polymerization of conjugated dienes and liquid polymers thereof | 雅宝公司 | 2023-06-30 | — | — | CN | claimed |
| CN-111741949-A | Method for the continuous separation by distillation of a mixture comprising Morpholine (MO), monoaminodiglycol (ADG), ammonia, water and Methoxyethanol (MOE) | 巴斯夫欧洲公司 | 2020-10-02 | — | — | CN | claimed |
| EP-1218353-A1 | QUINAZOLINE DERIVATIVES | AstraZeneca UK Limited (GB) | 2002-07-03 | — | — | EP | claimed |
| WO-2002002534-A1 | QUINAZOLINES WITH THERAPEUTIC USE | ASTRAZENECA AB (SE) | 2002-01-10 | — | — | WO | claimed |
| WO-2002000644-A1 | GUANIDINE DERIVATIVES OF QUINAZOLINE AND QUINOLINE FOR USE IN THE TREATMENT OF AUTOIMMUNE DISEASES | ASTRAZENECA AB (SE) | 2002-01-03 | — | — | WO | claimed |
| WO-2001066099-A2 | USE OF QUINAZOLINE DERIVATIVES AS ANGIOGENESIS INHIBITORS | ASTRAZENECA AB (SE) | 2001-09-13 | — | — | WO | claimed |
| WO-2001004102-A1 | QUINAZOLINE DERIVATIVES | ASTRAZENECA UK LIMITED (GB) | 2001-01-18 | — | — | WO | claimed |
| EP-0716084-A1 | Preparation of 4,4'-(oxydi-2,1-ethanediyl)bis-morpholine and hydroxyethoxyethyl morpholine | HUNTSMAN CORPORATION (US) | 1996-06-12 | — | — | EP | claimed |
| US-5429672-A | Silica effect control during metal deposition | HILEMN LABORATORIES, INC. (US) | 1995-07-04 | — | — | US | claimed |
| US-4556546-A | Bis tertiary amino alkyl derivatives as solvents for acid gas removal from gas streams | AIR PRODUCTS AND CHEMICALS, INC. (US) | 1985-12-03 | — | — | US | claimed |
| EP-0124835-A2 | BIS tertiary amino alkyl derivatives as solvents for acid gas removal from gas streams | AIR PRODUCTS AND CHEMICALS, INC. (US) | 1984-11-14 | — | — | EP | claimed |
| US-3976593-A | TRIETHANOLAMINE BISULFITE, CORROSION INHIBITOR | PETROLITE CORPORATION (US) | 1976-08-24 | — | — | US | claimed |